Our Experience list is sortable by client, brand name, (127) USAN/INN name, and therapeutic category:
Sort Clients By: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z || ALL
|
|
|
|
| REATA PHARMACEUTICALS | AIM - ANTIOXIDANT INFLAMMATION MODULATOR | Class Name | | REATA PHARMACEUTICALS | BARDOXOLONE METHYL | Nephrology | | RECKITT BENCKISER | MUCINEX * | Respiratory | | RECKITT BENCKISER | MUCINEX WITH CODEINE | Respiratory | | RELIANT PHARMACEUTICALS | INNOPRAN XL | Cardiovascular | | RELIANT PHARMACEUTICALS | LOVAZA | Cardiovascular | | RELIANT PHARMACEUTICALS | RYTHMOL SR | Cardiovascular | | RENESSEN | XENGROW AG | Veterinary | | REPLIDYNE | BEDEROCIN | Antibiotic | | RESEARCH TO PRACTICE | RESEARCH TO PRACTICE | Corporate ID | | ROCHE | ACTEMRA * | Rheumatology | | ROCHE | ALECARDIO | Clinical Trial Name | | ROCHE | BONIVA * | Endocrinology | | ROCHE | CERA - CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR | Class Name | | ROCHE | COPEGUS | Antiviral | | ROCHE | MIRCERA | Hematology | | ROCHE | PALOVAROTENE | Respiratory | | ROCHE | ROACTEMRA * | Rheumatology | | ROCHE | T-EMERGE | Clinical Trial Name | | ROCHE | TARCEVA * | Oncology | | ROCHE | TASPOGLUTIDE | Endocrinology | | ROCHE | XELODA | Oncology | | ROCHE | XENICAL | Obesity | | ROCHE | XUBIX | Cardiovascular | | ROXRO PHARMA | SPRIX | Pain & Inflammation |
* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA and/or EMEA, and/or Health Canada, and other Regulatory Agencies. |
|
Anglais
Espagnol
Japonais
Français
Allemand
L'Italien
